Asumalife is primarily composed of Ketotifen at a dosage of 1 mg, classified as a Histamine H1 receptor antagonist. It is commonly utilized in the treatment of symptoms associated with bronchial asthma, allergic rhinitis, and various other allergic conditions. Understanding comprehensive information such as composition, therapeutic indications, contraindications, dosage, and potential adverse effects of Asumalife will enhance treatment efficacy for patients and their families.